Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS

Clinical trial NCT02048228 · UNKNOWN

Trial details

NCT number: NCT02048228
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

CLOPIDOGREL, POOR METABOLISM of (Disorder)

Start date: 2014-10-01
Primary completion: 2016-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.